Health

How will new H-1B fees impact rural hospitals? – Healthcare Economist

• Health

How will new H-1B fees impact rural hospitals? – Healthcare Economist

Ak November 20, 2025

On September 19, 2025, an executive order increased the fee for new...

Read More Read more about How will new H-1B fees impact rural hospitals? – Healthcare Economist

Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable? – Healthcare Economist

• Health

Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable? – Healthcare Economist

Ak November 17, 2025

This is a recent incident biospace The article is titled “How effective...

Read More Read more about Is Direct to Consumer (DTC) drug pricing an effective way to make drugs more affordable? – Healthcare Economist

MFN comes to Medicaid under the GENEROUS program – Healthcare Economist

• Health

MFN comes to Medicaid under the GENEROUS program – Healthcare Economist

Ak November 14, 2025

Last week, CMS announced the GENERAS (cost-cutting for US Medicaid) model. The...

Read More Read more about MFN comes to Medicaid under the GENEROUS program – Healthcare Economist

ISPOR Europe 2025! – Healthcare Economist

• Health

ISPOR Europe 2025! – Healthcare Economist

Ak November 11, 2025

Excited to wrap up day one at ISPOR Europe in Glasgow, Scotland....

Read More Read more about ISPOR Europe 2025! – Healthcare Economist

How often do US commercial health plans apply coverage restrictions to cell and gene therapies? – Healthcare Economist

• Health

How often do US commercial health plans apply coverage restrictions to cell and gene therapies? – Healthcare Economist

Ak November 8, 2025

That’s the question a new paper by Chambers et al. (2025) aims...

Read More Read more about How often do US commercial health plans apply coverage restrictions to cell and gene therapies? – Healthcare Economist

Where Are We and Where Are We Going?” – Healthcare Economist

• Health

Where Are We and Where Are We Going?” – Healthcare Economist

Ak November 5, 2025

This is the title of my Fast Facts presentation at ISPOR Europe...

Read More Read more about Where Are We and Where Are We Going?” – Healthcare Economist

Health Wonk Review is Back! – Healthcare Economist

• Health

Health Wonk Review is Back! – Healthcare Economist

Ak November 2, 2025

Special thanks to Joe Paduda for bringing back the best review of...

Read More Read more about Health Wonk Review is Back! – Healthcare Economist

2025 Employer Health Benefits Survey – Healthcare Economist

• Health

2025 Employer Health Benefits Survey – Healthcare Economist

Ak October 30, 2025

2025 Employer Health Benefits Survey Came out last week. Here are some key findings: premium cost The...

Read More Read more about 2025 Employer Health Benefits Survey – Healthcare Economist

Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US – Healthcare Economist

• Health

Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US – Healthcare Economist

Ak October 27, 2025

This is the title of a paper published today future oncology With co-authors Erin Mulvey, Ki-Sin Thanh,...

Read More Read more about Patient preferences for attributes of bispecific antibodies for relapse/refractory diffuse large B-cell lymphoma in the US – Healthcare Economist

How to write a good grant proposal – Healthcare Economist

• Health

How to write a good grant proposal – Healthcare Economist

Ak October 24, 2025

How do you write a good grant proposal? How do you write...

Read More Read more about How to write a good grant proposal – Healthcare Economist